- Home
- EOSE vs OPCH Comparison
EOSE vs OPCH Comparison
Compare EOSE & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$6.32
HOLD
Current Price
$27.91
Company Overview
Basic Information| Metric | EOSE | OPCH |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | United States |
| Employees | 787 | N/A |
| Industry | Industrial Machinery/Components | Medical/Nursing Services |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 4.4B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | EOSE | OPCH |
|---|---|---|
| Price | $6.32 | $27.91 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 8 |
| Target Price | $11.08 | ★ $37.00 |
| AVG Volume (30 Days) | ★ 19.1M | 1.5M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.25 |
| EPS | N/A | ★ 1.27 |
| Revenue | N/A | ★ $4,998,202,000.00 |
| Revenue This Year | $173.95 | $7.21 |
| Revenue Next Year | $101.53 | $8.55 |
| P/E Ratio | ★ N/A | $22.79 |
| Revenue Growth | N/A | ★ 16.17 |
| 52 Week Low | $3.69 | $24.24 |
| 52 Week High | $19.86 | $36.80 |
Technical Indicators
Market Signals| Indicator | EOSE | OPCH |
|---|---|---|
| Relative Strength Index (RSI) | 53.08 | 41.31 |
| Support Level | $5.49 | $27.48 |
| Resistance Level | $6.79 | $28.90 |
| Average True Range (ATR) | 0.55 | 0.83 |
| MACD | 0.38 | 0.30 |
| Stochastic Oscillator | 88.27 | 52.76 |
Price Performance
Historical Comparison EOSE
OPCH
About EOSE Eos Energy Enterprises Inc.
Eos Energy Enterprises Inc designs develop, manufactures, and markets zinc-based energy storage solutions for utility-scale, microgrid, and commercial & industrial (C&I) applications. The solutions are used in the utility sector, the renewable energy sector, and the industrial sector.
About OPCH Option Care Health Inc.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.